Source: Eur Respir J 2013; 41: 1409-1418
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
Shang-Gin Wu, Chong-Jen Yu, Meng-Feng Tsai, Wei-Yu Liao, Chih-Hsin Yang, I-Shiow Jan, Pan-Chyr Yang, Jin-Yuan Shih. Survival of lung adenocarcinoma patients with malignant pleural effusion. Eur Respir J 2013; 41: 1409-1418

Member's Comments

No comment yet.

Related content which might interest you: Efficacy of EGFR-TKI for malignant pleural effusion in lung adenocarcinoma patients Source: International Congress 2017 – Mesothelioma and malignant pleural disease Year: 2017 Efficacy of pleurodesis for malignant pleural effusions in breast cancer patients Source: Eur Respir J 2011; 38: 1425-1430 Year: 2011 An update on treatment of malignant pleural effusion with or without known primary bronchial adenocarcinoma Source: Annual Congress 2006 - Medical and surgical management of malignant pleuritis Year: 2006 Oncodrivers in malignant pleural effusions associated with non-small cell lung cancer Source: Virtual Congress 2020 – Interventional pulmonology: the pleura and bronchoscopic treatment of emphysema Year: 2020 RNA is favourable for analysing EGFR mutations in malignant pleural effusion of lung cancer Source: Eur Respir J 2012; 39: 677-684 Year: 2012 Systemic treatment of malignant pleural effusion Source: Annual Congress 2005 - What's new in the pleura Year: 2005 Pleural effusion in lung cancer and targeted therapy Source: Hands-on Course 2013 - Medical Thoracoscopy Year: 2013 Clinical and biological prognostic factors in malignant pleural effusion (MPE) secondary to breast cancer Source: Annual Congress 2005 - What's new in the pleura Year: 2005 Evaluation of concomitant pleural effusions in patients with lung cancers Source: Eur Respir J 2007; 30: Suppl. 51, 668s Year: 2007 Malignant pericardial effusion in lung cancer patients Source: Annual Congress 2006 - Treatment and complications of treatment of lung cancer and malignant pleural effusions Year: 2006 Hypotonic carboplatin pleurodesis for malignant pleural effusion of non-small cell lung cancer Source: Eur Respir J 2002; 20: Suppl. 38, 273s Year: 2002 Pleural effusions in lung cancer Source: Annual Congress 2012 - Clinical issues in malignant pleural effusions Year: 2012 Diagnostic significance of ADAM8 in non-small cell lung cancer and malignant pleural effusion Source: Annual Congress 2008 - Diagnostic aspects in thoracic oncology Year: 2008 Epidemiology and clinical problems of orphant pleural adenocarcinoma Source: Annual Congress 2006 - Medical and surgical management of malignant pleuritis Year: 2006 Sensitivity of PD-L1 analysis from pleural effusion in non-small cell lung cancer Source: Virtual Congress 2020 – Novel directions in pleural disease: bench to bedside Year: 2020 Surgery for lung cancer with pleural effusion Source: Eur Respir J 2002; 20: Suppl. 38, 180s Year: 2002 Thoracoscopy in malignant pleural effusions secondary to breast cancer Source: Eur Respir J 2006; 28: Suppl. 50, 611s Year: 2006 High sensitivity of PD-L1 analysis from pleural effusion in nonsmall cell lung cancer Source: ERJ Open Res, 7 (1) 00787-2020; 10.1183/23120541.00787-2020 Year: 2021 Biological characteristics of dendritic cells from malignant pleural effusions in patients with lung cancer Source: Eur Respir J 2006; 28: Suppl. 50, 772s Year: 2006 Malignant pleural mesothelioma: new treatment modalities Source: Annual Congress 2005 - Clinical year in review Year: 2005